Insider Trading activities of Haemonetics Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp since year 2005. Table 2 shows the detailed insider transactions of Haemonetics Corp since 2005. The reporting company's ticker symbol is HAE. The reporting company's CIK number is 313143.
The total value of stock buying since 2005 is $9,297,802.
The total value of stock sales since 2005 is $178,733,533.
The total value of stock option exercises since 2005 is $85,065,087.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Haemonetics Corp (HAE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 0 $0 2,720 $281,259 1,457 $49,843
2018-11 0 $0 36,085 $4,124,159 19,428 $682,334
2018-10 0 $0 881 $89,588 0 $0
2018-09 0 $0 35,714 $3,986,594 29,310 $1,150,112
2018-07 0 $0 5,139 $458,964 0 $0
2018-06 0 $0 14,279 $1,329,389 9,430 $379,260
2018-04 0 $0 210 $15,159 0 $0
2018-03 0 $0 503 $36,331 0 $0
2018-01 0 $0 7,118 $448,434 7,118 $244,894
2017-12 0 $0 7,118 $406,331 7,118 $244,894
2017-11 0 $0 40,250 $2,198,545 39,338 $1,453,623
2017-10 0 $0 1,565 $72,811 0 $0
2017-08 0 $0 24,086 $1,013,105 24,086 $811,288
2017-07 0 $0 197 $7,956 0 $0
2017-06 0 $0 3,595 $145,202 0 $0
2017-05 0 $0 57,757 $2,361,151 57,757 $1,938,829
2017-03 0 $0 8,580 $343,200 8,580 $233,719
2016-12 0 $0 5,683 $229,024 0 $0
2016-10 0 $0 351 $11,990 0 $0
2016-08 60,000 $2,099,760 19,022 $671,433 8,580 $233,719
2016-07 0 $0 0 $0 11,758 $349,447
2015-10 0 $0 3,754 $120,085 0 $0
2015-09 0 $0 11,334 $400,691 11,334 $311,860
2015-08 0 $0 16,236 $636,894 16,236 $440,823
2015-07 0 $0 49,394 $1,983,158 46,730 $1,272,546
2015-06 0 $0 22,236 $942,827 22,236 $605,793
2015-05 0 $0 13,667 $558,613 13,667 $364,841
2015-04 0 $0 9,667 $415,753 9,667 $258,961
2015-03 0 $0 49,960 $2,198,902 53,581 $1,512,552
2015-02 0 $0 27,421 $1,186,169 27,421 $792,199
2015-01 0 $0 4,765 $177,253 4,765 $129,965
2014-12 0 $0 4,765 $174,980 4,765 $129,965
2014-11 0 $0 4,765 $170,887 4,765 $129,965
2014-10 0 $0 36,426 $1,282,814 36,426 $930,137
2014-08 0 $0 18,388 $655,975 15,708 $442,960
2014-07 0 $0 10,437 $374,662 10,437 $233,932
2014-06 0 $0 28,805 $980,526 28,805 $692,396
2014-05 0 $0 19,621 $624,366 19,621 $463,164
2014-04 0 $0 40,437 $1,258,294 40,437 $625,522
2014-03 0 $0 22,436 $815,428 22,436 $390,548
2014-02 0 $0 13,170 $502,601 11,290 $244,308
2014-01 0 $0 14,806 $606,299 14,806 $343,177
2013-12 0 $0 14,738 $630,702 14,738 $328,902
2013-11 0 $0 72,250 $2,870,392 69,000 $2,122,407
2013-10 0 $0 4,400 $176,214 4,400 $77,638
2013-09 0 $0 14,400 $574,803 14,400 $196,884
2013-08 0 $0 13,000 $549,406 13,000 $158,405
2013-07 0 $0 14,400 $605,933 14,400 $196,884
2013-06 0 $0 83,028 $3,510,777 83,028 $2,002,829
2013-05 0 $0 69,282 $2,818,808 69,282 $1,683,050
2013-04 3,224 $105,501 34,516 $1,434,777 34,516 $477,341
2013-03 0 $0 14,400 $591,395 14,400 $283,516
2013-02 0 $0 17,400 $725,931 14,400 $283,516
2013-01 0 $0 77,688 $3,232,854 77,688 $1,402,804
2012-12 0 $0 32,568 $1,314,985 44,684 $932,601
2012-11 793 $48,732 34,378 $2,768,317 33,092 $1,452,070
2012-10 0 $0 16,500 $1,335,649 16,500 $459,630
2012-09 0 $0 81,756 $6,125,894 81,756 $3,953,336
2012-08 0 $0 18,500 $1,318,418 18,500 $781,910
2012-07 0 $0 21,782 $1,611,609 21,782 $768,434
2012-06 0 $0 59,500 $4,280,537 59,500 $2,843,186
2012-05 2,049 $102,094 110,567 $7,924,739 104,319 $5,201,932
2012-04 0 $0 23,252 $1,599,559 29,252 $975,725
2012-03 0 $0 5,890 $391,300 5,000 $159,460
2012-02 0 $0 7,100 $462,997 7,100 $204,526
2012-01 0 $0 20,000 $1,240,535 20,000 $629,035
2011-12 0 $0 5,000 $293,800 5,000 $159,460
2011-11 785 $40,666 5,000 $288,500 5,000 $159,460
2011-10 0 $0 10,000 $592,080 10,000 $365,210
2011-09 0 $0 2,100 $121,995 2,100 $45,066
2011-08 0 $0 850 $50,779 0 $0
2011-07 0 $0 17,000 $1,154,970 17,000 $561,720
2011-06 0 $0 8,350 $552,436 8,350 $179,191
2011-05 1,958 $91,633 17,049 $1,147,457 16,592 $812,233
2011-03 0 $0 3,000 $195,000 3,000 $91,155
2011-02 0 $0 33,650 $2,065,461 33,650 $856,770
2010-12 0 $0 123,988 $7,600,153 123,988 $5,166,397
2010-11 1,468 $68,017 13,000 $753,065 7,000 $288,050
2010-09 0 $0 1,866 $102,316 0 $0
2010-05 0 $0 9,000 $513,171 0 $0
2010-04 2,006 $91,681 31,032 $1,861,311 19,867 $455,073
2010-03 0 $0 200,000 $11,400,026 200,000 $8,229,999
2010-02 0 $0 277,200 $14,825,932 2,200 $47,212
2009-10 1,019 $44,968 2,814 $155,298 1,870 $40,130
2009-09 0 $0 6,000 $334,698 6,000 $164,064
2009-05 2,356 $103,391 799 $42,906 0 $0
2009-03 4,500 $247,116 9,750 $506,317 9,750 $152,490
2009-02 0 $0 116,000 $6,990,950 116,000 $3,236,605
2009-01 0 $0 27,477 $1,546,920 25,000 $473,425
2008-12 0 $0 20,000 $1,160,000 20,000 $597,900
2008-11 3,500 $202,828 0 $0 0 $0
2008-10 505 $22,945 50,407 $2,837,909 50,000 $1,095,500
2008-09 0 $0 93,298 $6,001,970 93,298 $1,929,982
2008-08 0 $0 68,500 $4,221,432 68,500 $1,636,403
2008-07 0 $0 50,000 $2,750,000 50,000 $1,095,500
2008-06 0 $0 50,500 $2,885,000 50,500 $1,108,552
2008-05 6,199 $291,564 50,775 $2,795,566 50,000 $1,095,500
2008-04 0 $0 500 $27,990 500 $13,052
2008-03 0 $0 623 $36,578 400 $10,442
2008-02 0 $0 9,500 $557,669 9,500 $167,437
2008-01 0 $0 10,000 $619,800 10,000 $288,820
2007-11 1,199 $48,752 18,850 $1,084,168 18,850 $730,146
2007-07 0 $0 7,000 $369,502 7,000 $159,026
2007-06 0 $0 8,000 $408,000 8,000 $253,280
2007-05 3,517 $135,864 10,452 $522,354 10,000 $242,350
2007-04 0 $0 7,000 $336,000 7,000 $159,026
2007-02 0 $0 38,183 $1,797,337 38,183 $781,211
2006-11 1,824 $70,693 400 $18,306 0 $0
2006-09 0 $0 59,694 $2,715,121 59,694 $1,698,592
2006-08 4,442 $199,867 192,024 $8,647,055 192,024 $3,141,329
2006-07 0 $0 400 $18,682 0 $0
2006-06 100,000 $4,654,900 64,000 $3,039,200 63,000 $1,011,099
2006-05 2,347 $97,447 0 $0 0 $0
2006-03 0 $0 0 $0 30,200 $543,600
2006-02 2,110 $104,972 7,000 $351,400 7,000 $159,033
2005-11 6,203 $301,610 0 $0 0 $0
2005-09 1,000 $44,710 0 $0 0 $0
2005-05 3,290 $78,091 0 $0 0 $0
2005-04 0 $0 400 $30,800 0 $0
2004-04 0 $0 400 $11,820 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Haemonetics Corp insiders (HAE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-12 Scanlan Jacqueline (SVP, Global Human Resources) Sale 1,027 104.22 107,033
2018-12-10 Goldstein Dan (VP, Corporate Controller) Sale 1,693 102.91 174,226
2018-12-10 Goldstein Dan (VP, Corporate Controller) Option Ex 1,457 34.21 49,843
2018-11-08 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 13,056 114.33 1,492,692
2018-11-08 Burke William P. Mr. (EVP, Chief Financial Officer) Option Ex 11,232 34.21 384,246
2018-11-08 Granadillo Pedro P (Director) Sale 12,322 114.50 1,410,869
2018-11-07 Kroll Mark W (Director) Sale 10,707 114.00 1,220,598
2018-11-07 Kroll Mark W (Director) Option Ex 8,196 36.37 298,088
2018-10-26 Goldstein Dan (VP, Corporate Controller) Sale 102 101.69 10,372
2018-10-26 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 779 101.69 79,216
2018-09-17 Granadillo Pedro P (Director) Sale 30,824 111.54 3,437,985
2018-09-17 Granadillo Pedro P (Director) Option Ex 25,122 39.11 982,446
2018-09-10 Scanlan Jacqueline (SVP, Global Human Resources) Sale 4,890 112.19 548,609
2018-09-10 Scanlan Jacqueline (SVP, Global Human Resources) Option Ex 4,188 40.03 167,666
2018-07-02 Simon, Christopher (President & CEO) Sale 5,139 89.31 458,964
2018-06-25 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 6,687 92.17 616,340
2018-06-25 Burke William P. Mr. (EVP, Chief Financial Officer) Option Ex 5,717 41.64 238,055
2018-06-08 Goldstein Dan (VP, Corporate Controller) Sale 578 92.90 53,696
2018-06-07 Goldstein Dan (VP, Corporate Controller) Sale 81 92.73 7,511
2018-06-07 Scanlan Jacqueline (SVP, Global Human Resources) Sale 214 92.73 19,844
2018-06-07 Basil Michelle L (EVP and General Counsel) Sale 457 92.73 42,377
2018-06-07 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 425 92.73 39,410
2018-06-07 Simon, Christopher (President & CEO) Sale 1,941 92.73 179,988
2018-06-07 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 183 92.73 16,969
2018-06-06 Goldstein Dan (VP, Corporate Controller) Sale 3,713 95.14 353,254
2018-06-06 Goldstein Dan (VP, Corporate Controller) Option Ex 3,713 38.03 141,205
2018-04-06 Goldstein Dan (VP, Corporate Controller) Sale 210 72.19 15,159
2018-03-06 Scanlan Jacqueline (SVP, Global Human Resources) Sale 114 72.23 8,234
2018-03-06 Basil Michelle L (EVP and General Counsel) Sale 389 72.23 28,097
2018-01-02 Kroll Mark W (Director) Sale 7,118 63.00 448,434
2018-01-02 Kroll Mark W (Director) Option Ex 7,118 34.41 244,894
2017-12-01 Granadillo Pedro P (Director) Sale 7,118 57.09 406,331
2017-12-01 Granadillo Pedro P (Director) Option Ex 7,118 34.41 244,894
2017-11-16 Gelbman Ronald G (Director) Sale 5,440 56.68 308,350
2017-11-16 Gelbman Ronald G (Director) Option Ex 7,118 34.41 244,894
2017-11-14 Burke Willaim P (EVP, Chief Financial Officer) Sale 13,193 54.19 714,862
2017-11-14 Burke Willaim P (EVP, Chief Financial Officer) Option Ex 11,231 34.21 384,212
2017-11-13 Goldstein Dan (Chief Accounting Officer) Sale 4,691 54.91 257,606
2017-11-13 Goldstein Dan (Chief Accounting Officer) Option Ex 4,063 34.31 139,421
2017-11-10 Foote Susan Bartlett (Director) Sale 16,926 54.22 917,727
2017-11-10 Foote Susan Bartlett (Director) Option Ex 16,926 40.48 685,096
2017-10-25 Goldstein Dan (VP, Corporate Controller) Sale 111 46.76 5,190
2017-10-25 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 841 46.76 39,325
2017-10-25 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 267 46.76 12,484
2017-10-20 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 346 45.70 15,812
2017-08-10 Meelia Richard J (Director) Sale 24,086 42.06 1,013,105
2017-08-10 Meelia Richard J (Director) Option Ex 24,086 33.68 811,288
2017-07-19 Goldstein Dan (VP, Corporate Controller) Sale 197 40.39 7,956
2017-06-29 Simon, Christopher (President & CEO) Sale 3,595 40.39 145,202
2017-05-22 Merriman Ronald (Director) Sale 25,667 40.32 1,034,912
2017-05-22 Merriman Ronald (Director) Option Ex 25,667 34.41 865,091
2017-05-15 Kroll Mark W (Director) Sale 8,580 41.49 355,992
2017-05-15 Kroll Mark W (Director) Option Ex 8,580 27.24 233,719
2017-05-11 Foote Susan Bartlett (Director) Sale 15,314 41.78 639,818
2017-05-11 Foote Susan Bartlett (Director) Option Ex 15,314 35.39 541,931
2017-03-24 Gelbman Ronald G (Director) Sale 8,580 40.00 343,200
2017-03-24 Gelbman Ronald G (Director) Option Ex 8,580 27.24 233,719
2016-12-12 Gelbman Ronald G (Director) Sale 5,683 40.30 229,024
2016-10-20 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 351 34.16 11,990
2016-08-17 Merriman Ronald (Director) Sale 4,337 35.15 152,436
2016-08-05 Foote Susan Bartlett (Director) Sale 14,685 35.34 518,997
2016-08-05 Foote Susan Bartlett (Director) Option Ex 8,580 27.24 233,719
2016-08-04 Simon, Christopher (President & CEO) Buy 60,000 35.00 2,099,760
2016-07-29 Gelbman Ronald G (Director) Option Ex 11,758 29.72 349,447
2015-10-26 Selman Byron (President, Global Markets) Sale 344 32.13 11,052
2015-10-26 Jesse Sandra (EVP and Chief Legal Officer) Sale 778 32.13 24,996
2015-10-26 White Jonathan (Chief Science and Technology) Sale 319 32.13 10,249
2015-10-26 Lindop Christopher J (CFO & EVP Business Development) Sale 436 32.13 14,008
2015-10-26 Hanlon Susan M (VP Finance) Sale 497 32.13 15,968
2015-10-23 Selman Byron (President, Global Markets) Sale 191 31.75 6,064
2015-10-23 Jesse Sandra (EVP and Chief Legal Officer) Sale 250 31.75 7,937
2015-10-23 White Jonathan (Chief Science and Technology) Sale 250 31.75 7,937
2015-10-23 Davies Kent J (Chief Operating Officer) Sale 278 31.75 8,826
2015-10-23 Burns Brian R (EVP, Global QA/RA) Sale 249 31.75 7,905
2015-10-23 Hanlon Susan M (VP Finance) Sale 162 31.75 5,143
2015-09-15 Concannon Brian (President & CEO) Sale 6,569 35.15 230,900
2015-09-15 Concannon Brian (President & CEO) Option Ex 6,569 27.69 181,895
2015-09-01 Concannon Brian (President & CEO) Sale 4,765 35.63 169,791
2015-09-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-08-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 38.49 188,687
2015-08-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-08-17 Concannon Brian (President & CEO) Sale 6,569 39.28 258,017
2015-08-17 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-08-03 Concannon Brian (President & CEO) Sale 4,765 39.91 190,190
2015-08-03 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-07-23 Davies Kent J (President, Global Markets) Sale 279 39.36 10,981
2015-07-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 39.09 191,609
2015-07-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-07-15 Concannon Brian (President & CEO) Sale 6,569 39.59 260,092
2015-07-15 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-07-06 Allen Peter M (President, Global Plasma) Sale 30,494 40.19 1,225,645
2015-07-06 Allen Peter M (President, Global Plasma) Option Ex 30,494 27.27 831,723
2015-07-02 White Jonathan (Chief Science and Technology) Sale 2,385 41.14 98,118
2015-07-01 Concannon Brian (President & CEO) Sale 4,765 41.28 196,713
2015-07-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-06-22 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 42.51 208,393
2015-06-22 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-06-15 Concannon Brian (President & CEO) Sale 6,569 42.51 279,221
2015-06-15 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-06-10 Hanlon Susan M (VP Finance) Sale 6,000 43.00 258,000
2015-06-10 Hanlon Susan M (VP Finance) Option Ex 6,000 27.50 164,970
2015-06-01 Concannon Brian (President & CEO) Sale 4,765 41.39 197,213
2015-06-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-05-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 41.65 204,173
2015-05-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-05-05 Hanlon Susan M (VP Finance) Sale 4,000 40.08 160,300
2015-05-05 Hanlon Susan M (VP Finance) Option Ex 4,000 26.47 105,880
2015-05-01 Concannon Brian (President & CEO) Sale 4,765 40.74 194,140
2015-05-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-04-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 41.55 203,678
2015-04-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-04-01 Concannon Brian (President & CEO) Sale 4,765 44.51 212,075
2015-04-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-03-27 Hanlon Susan M (VP Finance) Sale 7,000 43.47 304,255
2015-03-27 Hanlon Susan M (VP Finance) Option Ex 7,000 26.47 185,290
2015-03-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 44.26 216,982
2015-03-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-03-10 Foote Susan Bartlett (Director) Sale 11,328 43.84 496,642
2015-03-10 Foote Susan Bartlett (Director) Option Ex 11,328 29.23 331,117
2015-03-05 Gelbman Ronald G (Director) Sale 7,707 44.76 344,934
2015-03-05 Gelbman Ronald G (Director) Option Ex 11,328 29.23 331,117
2015-03-04 Merriman Ronald (Director) Sale 14,258 43.80 624,471
2015-03-04 Merriman Ronald (Director) Option Ex 14,258 28.48 406,067
2015-03-02 Concannon Brian (President & CEO) Sale 4,765 44.41 211,618
2015-03-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-02-27 Kroll Mark W (Director) Sale 11,328 44.80 507,483
2015-02-27 Kroll Mark W (Director) Option Ex 11,328 29.23 331,117
2015-02-18 Granadillo Pedro P (Director) Sale 11,328 43.45 492,156
2015-02-18 Granadillo Pedro P (Director) Option Ex 11,328 29.23 331,117
2015-02-02 Concannon Brian (President & CEO) Sale 4,765 39.15 186,530
2015-02-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-01-02 Concannon Brian (President & CEO) Sale 4,765 37.20 177,253
2015-01-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-12-01 Concannon Brian (President & CEO) Sale 4,765 36.72 174,980
2014-12-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-11-03 Concannon Brian (President & CEO) Sale 4,765 35.86 170,887
2014-11-03 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-10-13 Allen Peter M (President, Global Plasma) Sale 36,426 35.22 1,282,814
2014-10-13 Allen Peter M (President, Global Plasma) Option Ex 36,426 25.54 930,137
2014-08-28 Mcdaniel Kathleen (EVP Global Human Resources) Sale 406 35.46 14,396
2014-08-12 Merriman Ronald (Director) Sale 13,602 35.81 487,114
2014-08-12 Merriman Ronald (Director) Option Ex 11,328 29.23 331,117
2014-08-01 Concannon Brian (President & CEO) Sale 4,380 35.27 154,465
2014-08-01 Concannon Brian (President & CEO) Option Ex 4,380 25.54 111,843
2014-07-07 Granadillo Pedro P (Director) Sale 5,837 35.95 209,863
2014-07-07 Granadillo Pedro P (Director) Option Ex 5,837 19.95 116,471
2014-07-01 Concannon Brian (President & CEO) Sale 4,600 35.83 164,799
2014-07-01 Concannon Brian (President & CEO) Option Ex 4,600 25.54 117,461
2014-06-12 Gelbman Ronald G (Director) Sale 9,184 34.00 312,283
2014-06-12 Gelbman Ronald G (Director) Option Ex 9,184 24.96 229,232
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.